Exploring the role of T cells in Alzheimer's disease, suggests new treatment strategies

Published Date: 10 Mar 2023

Nearly two dozen clinical trials targeting the immune system are in clinical trials for Alzheimer's disease.

Read Full News

Latest News

Favorable Outcomes Follow Previable Membrane Rupture

Most survivors after previable preterm prelabor rupture of membranes show favorable neurodevelopment at 2-3 years, a study suggests.

Wildfire Smoke Linked to Increase in ED Visits for Migraine

Exposure to wildfire-sourced fine particulate matter is linked to increased emergency department visits for migraine and other primary headache syndromes, a study shows.

Large Study Describes Genetic Underpinning of Fibromyalgia

‘This study provides important new insights into why some people develop fibromyalgia syndrome and identifies biological pathways that could lead to new treatment approaches,’ a study co-author says.

FDA Flags Data Concerns About Experimental DMD Therapy

U.S. FDA staff reviewers raised concerns about the effectiveness data for Capricor Therapeutics' cell therapy for a heart condition related ⁠to Duchenne muscular dystrophy,...

Personalized Gene Therapy Promising in Rare Epilepsy

Individualized gene therapies reduce seizures and lead to developmental gains in two boys with severe, treatment-resistant SCN2A-related epilepsy.

US FDA Approves Over-the-counter Tylenol Combination Pill for Pain Relief

The U.S. Food and Drug Administration on Friday approved a nonprescription, fixed-dose ⁠pill that combines Kenvue's Tylenol with the nonsteroidal anti-inflammatory drug...

Todays Updates

Dual Checkpoint Blockade Boosts Breast Cancer pCR

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Todays Updates

Dual Checkpoint Blockade Boosts Breast Cancer pCR

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Latest News

Most survivors after previable preterm prelabor rupture of membranes show favorable neurodevelopment at 2-3 years, a study suggests.

Exposure to wildfire-sourced fine particulate matter is linked to increased emergency department visits for migraine and other primary headache syndromes, a study shows.

‘This study provides important new insights into why some people develop fibromyalgia syndrome and identifies biological pathways that could lead to new treatment approaches,’ a study co-author says.

U.S. FDA staff reviewers raised concerns about the effectiveness data for Capricor Therapeutics' cell therapy for a heart condition related ⁠to Duchenne muscular dystrophy,...

Individualized gene therapies reduce seizures and lead to developmental gains in two boys with severe, treatment-resistant SCN2A-related epilepsy.

The U.S. Food and Drug Administration on Friday approved a nonprescription, fixed-dose ⁠pill that combines Kenvue's Tylenol with the nonsteroidal anti-inflammatory drug...

News All Time

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

What Is Causing This Case of Sudden Aphasia?

Clues come from a kidney injury, encephalop­athy, and drug dosing error

Neuropathy After Recreational Use of Laughing Gas

Clinicians should be aware of adverse effects of this increasingly popular drug

Vitamin C and the Brain; Invisible MS Lesions Revealed; Profound Autism Definition

News and commentary from the world of neurology and neuroscience

Alzheimer's Biomarkers Change After Tuberculosis Vaccination

BCG vaccine altered immune responses and modified amyloid-beta, study shows

Modified Amino Acid Improves Neurologic Symptoms in Rare Genetic Disorder

— Levacetylleucine succeeds in phase III trial of adults and kids with ataxia-telangiectasia

Third Molar Extraction: Benefit or Overtreatment?

Third molar removal may improve oral health markers, but its benefits must be weighed against surgical risks, postoperative morbidity, and cost.

Quick Case Challenge: Implementing FcRn Antagonists in gMG Practice

Quick Case Challenge: Implementing FcRn Antagonists in gMG Practice

Brain Risks Tied to High Ultraprocessed Food Intake

Longitudinal study links heavily processed food with a sharp increase in cognitive impairment

RFK Jr. Seeks to Peek at Americans' Medical Records for Clues on Autism and Vaccines

Some public health leaders have raised doubts that giving access would be legal or even useful

MAHA's Autism Treatments: Camel's Milk, Stem Cell Injections, and Spelling Therapy

Experts say some of the methods may be fraudulent

Brain Institute Halts Research; Parkinson's Deaths Fall; Meet the 'Dementia Rebels'

News and commentary from the world of neurology and neuroscience

Primitive Reflexes May Predict Dementia

Two or more frontal release signs in cognitively normal people tied to higher risk of dementia

Genetic Risk of Autism, ADHD Decreased as Diagnoses Increased

Study offers "new perspective for ongoing debates" about increasing diagnoses, researchers say

Alzheimer's May Be Worse for People Taking Popular Supplement

Glucosamine tied to faster progression in people with established neurodegeneration

Report: Law Firms Cheated in Filing Claims With NFL's Concussion Settlement Fund

The fund was meant to last for 65 years

Recommended News For You

When a Groundbreaking Cancer Therapy Causes Cancer.

Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.

Novel ADC Improves Survival in Metastatic TNBC

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

What Kate Middleton Reminds Us About the Role of Privacy in Healing.

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

Researchers study effects of cannabis on sedation, cancer treatment symptoms

Recommended Articles For You

The benefits and risks of taking fludrocortisone for adrenal insufficiency  

How Bispecific Antibodies are Redefining Medical Oncology in the US - A 2025 Review 

Living Better With Advanced Cancer Through Supportive Care 

CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Obesity-related cancer rising among both younger and older adults worldwide, study finds

2.

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

3.

Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.

4.

The way that miR-377 inhibits cells that cause prostate cancer.

5.

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.

1.

Environmental Carcinogen Exposure Screening: Advances, Clinical Implications, and Guideline-Based Approaches

2.

Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment

3.

Respiratory Ramifications of Systemic Disease: A Comprehensive Review

4.

Genetic Screening: A Game Changer in Cancer Prevention

5.

Uncovering the Reality of Colon Cancer: A Look at Real Images

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

2.

Navigating the Complexities of Ph Negative ALL - Part XII

3.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

5.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot